Continuous glucose monitoring (CGM) devices are attached to the skin and utilize a needle-like sensor inserted into the subcutaneous tissue to measure glucose within interstitial fluid (ISF).2–4 This revolutionary technology facilitates better management of BG levels by providing a continuous data stream, with user feedback, that can reduce postprandial glucose excursions and the incidence of hypoglycemia and hyperglycemia.5–8